Literature DB >> 35261216

Transition of autophagy and apoptosis in fibroblasts depends on dominant expression of HIF-1α or p53.

Min Li1, Yidan Su2, Xiaoyuan Gao1, Jiarong Yu1, Zhiyong Wang3, Xiqiao Wang4.   

Abstract

It has been revealed that hypoxia is dynamic in hypertrophic scars; therefore, we considered that it may have different effects on hypoxia-inducible factor-1α (HIF-1α) and p53 expression. Herein, we aimed to confirm the presence of a teeterboard-like conversion between HIF-1α and p53, which is correlated with scar formation and regression. Thus, we obtained samples of normal skin and hypertrophic scars to identify the differences in HIF-1α and autophagy using immunohistochemistry and transmission electron microscopy. In addition, we used moderate hypoxia in vitro to simulate the proliferative scar, and silenced HIF-1α or p53 gene expression or triggered overexpression to investigate the changes of HIF-1α and p53 expression, autophagy, apoptosis, and cell proliferation under this condition. HIF-1α, p53, and autophagy-related proteins were assayed using western blotting and immunofluorescence, whereas apoptosis was detected using flow cytometry analysis, and cell proliferation was detected using cell counting kit-8 (CCK-8) and 5-bromo-2'-deoxyuridine (BrdU) staining. Furthermore, immunoprecipitation was performed to verify the binding of HIF-1α and p53 to transcription cofactor p300. Our results demonstrated that, in scar tissue, HIF-1α expression increased in parallel with autophagosome formation. Under hypoxia, HIF-1α expression and autophagy were upregulated, whereas p53 expression and apoptosis were downregulated in vitro. HIF-1α knockdown downregulated autophagy, proliferation, and p300-bound HIF-1α, and upregulated p53 expression, apoptosis, and p300-bound p53. Meanwhile, p53 knockdown induced the opposite effects and enhanced HIF-1α, whereas p53 overexpression resulted in the same effects and reduced HIF-1α. Our results suggest a teeterboard-like conversion between HIF-1α and p53, which is linked with scar hyperplasia and regression.

Entities:  

Keywords:  Apoptosis; Autophagy; Hypertrophic scar; Hypoxia-inducible factor-1α (HIF-1α); p53

Mesh:

Substances:

Year:  2022        PMID: 35261216      PMCID: PMC8913927          DOI: 10.1631/jzus.B2100187

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  34 in total

1.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.

Authors:  Y Kabeya; N Mizushima; T Ueno; A Yamamoto; T Kirisako; T Noda; E Kominami; Y Ohsumi; T Yoshimori
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

Review 2.  Biological Functions of Autophagy Genes: A Disease Perspective.

Authors:  Beth Levine; Guido Kroemer
Journal:  Cell       Date:  2019-01-10       Impact factor: 41.582

Review 3.  Hypoxia--a key regulatory factor in tumour growth.

Authors:  Adrian L Harris
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

Review 4.  Hypertrophic scarring: the greatest unmet challenge after burn injury.

Authors:  Celeste C Finnerty; Marc G Jeschke; Ludwik K Branski; Juan P Barret; Peter Dziewulski; David N Herndon
Journal:  Lancet       Date:  2016-10-01       Impact factor: 79.321

5.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

6.  Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha.

Authors:  W G An; M Kanekal; M C Simon; E Maltepe; M V Blagosklonny; L M Neckers
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

7.  Dynamic biological changes in fibroblasts during hypertrophic scar formation and regression.

Authors:  Qing Chun; Wang ZhiYong; Song Fei; Wang XiQiao
Journal:  Int Wound J       Date:  2014-05-07       Impact factor: 3.315

8.  Beclin-1-Dependent Autophagy Protects the Heart During Sepsis.

Authors:  Yuxiao Sun; Xiao Yao; Qing-Jun Zhang; Min Zhu; Zhi-Ping Liu; Bo Ci; Yang Xie; Deborah Carlson; Beverly A Rothermel; Yuxiang Sun; Beth Levine; Joseph A Hill; Steven E Wolf; Joseph P Minei; Qun S Zang
Journal:  Circulation       Date:  2018-11-13       Impact factor: 39.918

9.  HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia.

Authors:  Valentina Griggio; Candida Vitale; Maria Todaro; Chiara Riganti; Joanna Kopecka; Chiara Salvetti; Riccardo Bomben; Michele Dal Bo; Daniela Magliulo; Davide Rossi; Gabriele Pozzato; Lisa Bonello; Monia Marchetti; Paola Omedè; Ahad Ahmed Kodipad; Luca Laurenti; Giovanni Del Poeta; Francesca Romana Mauro; Rosa Bernardi; Thorsten Zenz; Valter Gattei; Gianluca Gaidano; Robin Foà; Massimo Massaia; Mario Boccadoro; Marta Coscia
Journal:  Haematologica       Date:  2019-07-09       Impact factor: 9.941

10.  HOXA5 counteracts the function of pathological scar-derived fibroblasts by partially activating p53 signaling.

Authors:  Yimin Liang; Renpeng Zhou; Xiujun Fu; Chen Wang; Danru Wang
Journal:  Cell Death Dis       Date:  2021-01-05       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.